However, patients transferred to academic or large hospitals had significantly reduced mortality in another study.17 One possible reason for this is that the subject of the previous study was focused on patients with a history of stroke receiving some form of active stroke intervention (eg, intravenous tissue plasminogen activator, thrombectomy).17 This is a critically ill group who should be treated and given further care in medical centers. The gene discussed is PLAT; the disease is stroke disorder.